{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:15Z","timestamp":1787032875290,"version":"build-2736575974"},"reference-count":0,"publisher":"The Permanente Federation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TPJ"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.7812\/tpp\/20.034","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T22:35:31Z","timestamp":1608590131000},"page":"1-1","source":"Crossref","is-referenced-by-count":6,"title":["Immune-related Adverse Effects Associated with Programmed Death-1 Inhibitor Therapy in the Treatment of Non-Small Cell Lung Cancer: Incidence, Management, and Effect on Outcomes"],"prefix":"10.7812","volume":"25","author":[{"given":"Timothy","family":"Chiu","sequence":"first","affiliation":[{"name":"Drug Intelligence & Strategy, Kaiser Permanente California Regions, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, Ronald Reagen Medical Center, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Niu","sequence":"additional","affiliation":[{"name":"Pharmacy Outcomes Research Group, Kaiser Permanente California Regions, Downey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Moon","sequence":"additional","affiliation":[{"name":"Hematology-Oncology, Kaiser Permanente Southern California Region"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thach-Giao","family":"Truong","sequence":"additional","affiliation":[{"name":"Hematology-Oncology, Kaiser Permanente Southern California Region"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cooper","sequence":"additional","affiliation":[{"name":"Hematology-Oncology, Kaiser Permanente Southern California Region"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Hui","sequence":"additional","affiliation":[{"name":"Pharmacy Outcomes Research Group, Kaiser Permanente California Regions, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4708","container-title":["The Permanente Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T10:21:53Z","timestamp":1658226113000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thepermanentejournal.org\/doi\/10.7812\/TPP\/20.034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.7812\/TPP\/20.034"],"URL":"https:\/\/doi.org\/10.7812\/tpp\/20.034","relation":{},"ISSN":["1552-5775"],"issn-type":[{"value":"1552-5775","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}